SHANGHAI, Jan. 20, 2025 /PRNewswire/ — The Vanguard 1P trackers of TrinaTracker, a subsidiary of Trinasolar, have received Carbon Footprint Verification from the global inspections, certifications and laboratory testing provider Bureau Veritas. The certification process encompasses raw material procurement, pre-processing, manufacturing and transportation. This certification affirms that the greenhouse gas emissions of the Vanguard 1P trackers throughout their lifecycle comply with the requirements set forth in ISO 14067:2018 (Greenhouse gases — Carbon footprint of products — Requirements and guidelines for quantification). TrinaTracker, a leading smart tracking system provider, is committed to delivering innovative, sustainable and low-carbon products to its global customer base. The latest certification not only underscores this commitment but also establishes a benchmark for sustainable development worldwide.

Bureau Veritas, founded in 1828 and based in France, provides independent verification services in many areas, including quality, environmental management, occupational health and safety, and social responsibility, with certifications that are globally trusted.

In October TrinaTracker was honored with the Green Supply Chain Leadership Award by Bureau Veritas for its exceptional contributions to incorporating green principles throughout the entire supply chain, accelerated green transformation of supply chains, promoting resource efficiency and minimizing environmental impact through technological innovation.

TrinaTracker’s outstanding carbon footprint performance reflects a strong commitment to the sustainability management philosophy of Trinasolar. The company achieved several significant milestones in its green development journey last year: In March the global safety science leader UL Solutions awarded Trinasolar’s full range of Vertex N products with Product Carbon Footprint Certification; in June TrinaTracker’s manufacturing plant in Viana, Spain, received Bureau Veritas’ Organizational Carbon Footprint Certification; and in November Trinasolar’s Vertex N PV modules passed the rigorous carbon emissions review conducted by the French Energy Regulatory Commission, earning French Carbon Footprint Certification and securing market access to France.

Trinasolar is deeply committed to combating climate change and will continue to reduce carbon emissions across its operations and value chain. By advancing zero-carbon operations, establishing a zero-carbon value chain and producing zero-carbon products, Trinasolar aims to create a zero-carbon model. This commitment not only supports the global fight against climate change but also reinforces the company’s dedication to environmental protection and making a significant contribution to the transition to sustainable energy.

SHENZHEN, China, Jan. 20, 2025 /PRNewswire/ — CHIGEE, the innovative motorcycle riding system manufacturer, announces its first-ever appearance at AIMExpo 2025, North America’s premier powersports trade show. From February 5-7, 2025, CHIGEE will showcase its complete product lineup alongside the highly anticipated AIO-6 at the Las Vegas Convention Center’s South Hall, booth #8088.

“We’re looking forward to meeting with riders and industry professionals at AIMExpo,” said the CHIGEE team. “This event provides an excellent opportunity to showcase our advanced riding systems and develop our distribution network in North America.”

The CHIGEE team will be available throughout the show for product demonstrations and technical consultations. As part of our North American expansion, we welcome distributors and dealers to explore partnership opportunities. Interested parties can apply via this form.

Show attendees can experience hands-on demonstrations of CHIGEE’s full product range, including a preview of the new AIO-6 system. The new AIO-6 introduces a larger 6-inch screen with all-new UI design, bringing riders a more intuitive and clearer navigation experience. To stay updated on product launches and show specials, follow CHIGEE on Facebook or visit the official website.

Event Details:

• Date: February 5-7, 2025
• Location: Las Vegas Convention Center – South Hall
• Booth: #8088

Launching in 2024 with Apple CarPlay and Android Auto integration, the CHIGEE AIO-5 series embodies a clear mission: bringing smart technology to all riders. This versatile system fits most motorcycles and provides essential features like real-time navigation and sunset times to better plan your trip. Equipped with comprehensive dash cam features, the top-tier AIO-5 Lite safeguards your rides by recording and storing vital video evidence.

Riders are finding their journeys truly improved with CHIGEE’s innovative smart system. “As a daily commuter and weekend touring enthusiast, CHIGEE’s system has been a game-changer for me. The GPS navigation is crystal clear even in bright sunlight, and I no longer need to stop every time I get a message – CarPlay handles that seamlessly. The dash cam gives me extra peace of mind, especially during group rides. It’s like upgrading from a flip phone to a smartphone – you don’t realize how much you needed it until you have it.” — Touring enthusiast, California, USA.

To schedule a meeting at AIMExpo 2025 or learn more about CHIGEE products, please visit chigee.com or contact press@chigeego.com. For media inquiries, including high-resolution product images, company details, and technical specifications, please visit our press room.

About CHIGEE

CHIGEE, founded in 2020, pioneers motorcycle smart technology. The name CHIGEE derives from ‘riding technology’ in Chinese, reflecting the company’s mission to create innovative devices that transform riding experiences. With extensive R&D and global testing, CHIGEE delivers exceptional products for riders worldwide.

Facebook: Chigee Global
Instagram: @chigeeglobal
Youtube: Chigee Official

Contact Information
CHIGEE PR Team
Email: press@chigeego.com
Website: www.chigee.com

PANAMA CITY, Jan. 20, 2025 /PRNewswire/ — BingX, a global leader in cryptocurrency exchanges, has solidified its position as an industry innovator by becoming the first exchange to offer spot trading services for $TRUMP, which launched on January 18 at 12:50 (UTC+8), followed by the introduction of coin-margined futures trading for $TRUMP the very next day. Furthermore, BingX provided users with the earliest access to perpetual trading for $MELANIA, along with spot trading support. These efforts align with BingX’s broader strategy to expand its product offerings and provide users with a cutting-edge trading experience.

Digital assets like $TRUMP and $MELANIA are part of the rising trend of meme coin — cryptocurrencies inspired by cultural movements or popular figures. These tokens’ value is primarily driven by community interest and market activity. BingX’s support for such assets shows its dedication to addressing the growing demand for a variety of trading options in the crypto space.

$TRUMP stands out with its Coin-Margined Futures on BingX, providing traders with advanced tools to diversify their trading strategies. Users now are able to trade $TRUMP with the margin for futures trading on BingX, enhancing portfolio flexibility and capital efficiency. $MELANIA is currently supported by both spot and perpetual futures trading pairs, providing both experienced traders and newcomers plenty of trading options to choose from.

In addition to the listing of $TRUMP and $MELANIA, BingX has launched several campaigns to enhance the trading experience for its users. Starting January 18 at 14:00 (UTC+8), BingX introduced zero-fee trading for $TRUMP. Additionally, users can participate in various promotions to win tokens and airdrops through deposits and trading activities.

“The rise of personality-driven tokens like $TRUMP and $MELANIA reflects a broader trend where the crypto market intersects with finance and social movements.” Vivien Lin, Chief Product Officer of BingX, commented on the significance of these new listings: “These tokens are more than just monetary assets; they capture identity and sentiment. As these assets evolve within the broader blockchain ecosystem, it’s essential for platforms like BingX to innovate with products that balance volatility with educational resources, empowering users to navigate this dynamic landscape. Our focus remains on creating a robust platform that supports diverse investments while ensuring transparency and security.”

About BingX 

Founded in 2018, BingX is a leading crypto exchange, serving over 10 million users worldwide. BingX offers diversified products and services, including spot, derivatives, copy trading, and asset management – all designed for the evolving needs of users, from beginners to professionals. BingX is committed to providing a trustworthy platform that empowers users with innovative tools and features to elevate their trading proficiency. In 2024, BingX proudly became the official crypto exchange partner of Chelsea Football Club, marking an exciting debut in the world of sports.

For more information please visit: https://bingx.com/

SHENZHEN, China, Jan. 20, 2025 /PRNewswire/ — CES 2025, held from January 7-10 at the Las Vegas Convention Center, once again solidified its role as the premier global platform for technological innovation, with ZHAOWEI (Shenzhen ZHAOWEI Machinery & Electronics Co., Ltd) making a strong impression. As a leading provider of intelligent robotics and high-performance motor solutions, ZHAOWEI showcased its groundbreaking Dexterous Hand, alongside other pioneering solutions across consumer electronics, automotive, and medical sectors. These innovations reinforced ZHAOWEI’s position as a key player in shaping the future of robotics and micro-drive systems.

The exhibition attracted significant attention from some of the most influential leaders in the technology and manufacturing industries. Notably, ZHAOWEI’s booth was visited by Seok Woo Nam, Chief Technology Officer of Samsung, as well as senior representatives from Apple, Amazon, TCL, Sony, and Fuji. These high-profile visitors underscored the growing importance of ZHAOWEI’s innovations and highlighted the company’s pivotal role in advancing next-generation technologies.

Key Product Highlights

ZHAOWEI’s Dexterous Hand was one of the most talked-about exhibits at CES 2025. Visitors had the opportunity to experience the hand’s real-time demonstrations, interacting with its intricate capabilities of visual sensing, tactile perception and remote control. Here is what makes this model a standout:

Advanced Flexibility and Precision

• 17-20 Degrees of Freedom: Leveraging a sophisticated blend of parallel and linear motors, the product’s expansive range of motion makes it capable of handling complex, intricate tasks with exceptional accuracy, which is highly desirable in industries such as manufacturing, healthcare, and logistics.
• Independent Joint Movement: Each joint’s autonomy allows for precise, coordinated operations, such as gripping, twisting, and delicate object manipulation with exceptional accuracy. This function is critical for tasks like assembly, surgery, or even handling delicate materials.

Human-like Dexterity

• The human-like movement facilitated by the combination of independent finger control and force feedback makes it an ideal solution for environments where human-like interaction with objects is required, such as collaborative robotics in industries or prosthetic devices.
• This feature enhances its appeal in sectors requiring high adaptability, such as medical robotics, where the ability to perform delicate procedures or handle various instruments with care is crucial.

Compact and Durability

• Its compact and lightweight design makes it perfect for integration into existing robotic systems where space is limited or weight is a concern. This is particularly advantageous for industries that require lightweight solutions without sacrificing performance, such as drones, automation in tight spaces, and wearable robotics.
• Built to withstand continuous use, the durability and long service life of the Dexterous Hand ensure it delivers long-term value. This is especially important in industries where high-volume, continuous operation is necessary, reducing the need for frequent maintenance or replacements.

“We are proud to have participated in CES 2025 and to have engaged with some of the most influential figures in the global tech landscape,” said Li Haizhou, Chairman of ZHAOWEI. “This year’s exhibition provided us with an invaluable opportunity to showcase our latest advancements and forge meaningful connections with key stakeholders. We look forward to continuing our efforts in shaping the future of intelligent systems and driving technological progress across multiple sectors.”

ZHAOWEI is unwavering in its commitment to sustaining its innovative spirit and expanding its global influence. A key part of the company’s growth strategy is its international expansion, with a particular focus on strengthening its presence in the North American market. In July 2024, ZHAOWEI established its fully owned U.S. subsidiary, ZW Drive Inc. This strategic move is designed to enhance the company’s service capabilities in North America, meet local market demands more effectively, and foster closer collaboration with customers and partners in the region.

About ZHAOWEI

Founded in 2001, ZHAOWEI specializes in developing advanced micro drive systems. With over two decades of experience in the field of micro drive, ZHAOWEI’s expertise not only lies in providing a wide option of high-performance motors but also in developing tailored drive systems for clients’ applications. Known for its relentless commitment to innovation and quality, ZHAOWEI partners with global leaders to deliver technologies that drive progress and enhance human life.

SHANGHAI, Jan. 20, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that KJ-C2320, an allogeneic CAR T-cell therapy targeting CD38, has administered the first dose to a patient in an investigator-initiated trial (IIT).

KJ-C2320 is developed based on CARsgen’s THANK-uCAR^® platform. An investigator-initiated trial is ongoing in China to evaluate KJ-C2320 for the treatment of relapsed/refractory acute myeloid leukemia (R/R AML).

About THANK-uCAR^®

THANK (Target to Hinder the Attack of NK cells)-uCAR^® is CARsgen’s proprietary technology to generate allogeneic CAR-T cells with improved expansion and persistence by modifying donor-derived T cells. To minimize graft versus host disease (GvHD) and host versus graft response (HvGR) from allogeneic T cells, we disrupt the genomic loci encoding TCR and beta-2 microglobulin (B2M) to eliminate surface expression of the TCR or the human leukocyte antigen class I (HLA-I), an approach that has been validated by previous research. However, natural killer (NK) cells can attack T cells without HLA-I expression, which then limits the expansion and persistence of the allogeneic CAR-T cells. To protect the allogeneic CAR-T cells from the patient’s NK cells’ attacks, we arm these TCR^–/B2M^–T cells with a CAR that recognizes NKG2A to hinder the NKG2A-positive NK cell rejection of the CAR T cells and therefore allow the THANK-uCAR-T cells to resist the attack by NK cells. Clinical studies have demonstrated that the BCMA CAR-T therapy developed on the THANK-uCAR^® platform can expand in patients achieving complete response to levels comparable to autologous CAR-T, showing preliminary evidence of controllable safety and promising efficacy.

About CARsgen Therapeutics Holdings Limited

CARsgen is a biopharmaceutical company with operations in China and the U.S., focusing on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. CARsgen has established a comprehensive CAR T-cell research and development platform that covers target discovery, innovative CAR T-cell development, clinical trials, and commercial-scale production. Internally, CARsgen has developed novel technologies and a product pipeline with global rights to address significant challenges faced by existing CAR T-cell therapies. Efforts include improving safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs. CARsgen’s mission is to become a global biopharmaceutical leader that provides innovative and differentiated cell therapies for cancer patients worldwide and makes cancer curable.

Forward-looking Statements

All statements in this press release that are not historical fact or that do not relate to present facts or current conditions are forward-looking statements. Such forward-looking statements express the Group’s current views, projections, beliefs and expectations with respect to future events as of the date of this press release. Such forward-looking statements are based on a number of assumptions and factors beyond the Group’s control. As a result, they are subject to significant risks and uncertainties, and actual events or results may differ materially from these forward-looking statements and the forward-looking events discussed in this press release might not occur. Such risks and uncertainties include, but are not limited to, those detailed under the heading “Principal Risks and Uncertainties” in our most recent annual report and interim report and other announcements and reports made available on our corporate website, https://www.carsgen.com. No representation or warranty is given as to the achievement or reasonableness of, and no reliance should be placed on, any projections, targets, estimates or forecasts contained in this press release.

Contact CARsgen

For more information, please visit https://www.carsgen.com/

TAMPA, Fla., Jan. 20, 2025 /PRNewswire/ — Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the successful completion of patient enrolment in the SirPAD Trial, with over 1,250 patients now enrolled.

Concept Medical proudly announces that over 1,250 patients have successfully enrolled in the SirPAD Trial.

The SirPAD (Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated or uncoated balloon) randomised controlled trial is the world’s largest study evaluating the treatment of Peripheral Artery Disease (PAD) using the MagicTouch PTA Sirolimus Coated Balloon (Concept Medical Inc.) versus uncoated balloons and one of the largest device studies ever performed for PAD.

More than 1,250 patients have been enrolled and will be followed up at 12 months to assess the primary outcome of major adverse limb events (MALE). Final results are expected by Q1-Q2 2026.

SirPAD is an investigator-initiated, multi-centre, randomized, open-label trial that aims to determine whether the MagicTouch PTA sirolimus-coated balloon is non-inferior to plain old balloon angioplasty (POBA). The trial will also explore the potential for superiority.

Principal Investigators Prof. Dr. med. Nils Kucher and Prof. Dr. med. Stefano Barco, from the University Hospital Zurich, who leads this ambitious study, said, “Sirolimus-coated balloons represent a promising technology in treating symptomatic PAD, supported by evidence primarily from studies with surrogate endpoints. While trials like SIRONA and ongoing studies such as SirPAD are expanding knowledge, robust data from randomized controlled trials with clinical outcomes are needed to guide treatment and shape future guidelines. This result, having been able to randomize so many patients in a PAD device study, is unprecedented and we are very thankful to all investigators and patients for having supported the trial” on achieving the significant milestone of enrolling 1,250+ patients and successfully completing this phase of the study.

With sirolimus-coated balloons gathering global momentum and MagicTouch PTA at the forefront, SirPAD is a crucial milestone in expanding the evidence for PAD treatment options. While patients with PAD have limited therapeutic avenues, SirPAD aims to bolster data supporting sirolimus-coated balloon technology. This large RCT was critical to evaluating treatment alternatives, and its year-long follow-up will provide much-anticipated answers.

“At Concept Medical, we are committed to generating robust clinical evidence to support our innovative technologies. Following the successful completion of SIRONA—the largest superficial femoral artery (SFA) trial comparing our device against paclitaxel drug-coated balloons (DCBs), which demonstrated non-inferiority—we are proud to announce the completion of enrollment for another historical milestone: the largest randomised clinical trial for peripheral all-comers patients, completed enrolment of 1250+ patients. With this achievement, Concept Medical continues to lead the way with the most extensive and advanced clinical trial program in the field, reinforcing our position as a global pioneer in patient-centric vascular innovations,” said Dr. Manish Doshi, Founder & Managing Director of Concept Medical.

About Concept Medical

Concept Medical Inc., headquartered in Tampa, Florida, has a global presence and is dedicated to enhancing patient care through cutting-edge research and development of drug-delivery technologies. Its proprietary platforms are designed to deliver pharmaceutical agents across vascular luminal surfaces with unparalleled precision. Concept Medical is the developer of the MagicTouch family of Sirolimus Coated Balloons (SCBs)—the world’s first and most utilized SCB technology—well recognized for its versatility and efficacy in treating coronary and peripheral artery disease. The revolutionary MagicTouch and Abluminus product lines have been used to treat over a million patients globally, setting a new standard for vascular therapy.

For more information, please visit www.conceptmedical.com

LOS BAÑOS, Philippines, Jan. 20, 2025 /PRNewswire/ — The International Rice Research Institute (IRRI) and smart agriculture technology leader XAG are set to accelerate agricultural automation and innovation in the Philippines through digital agriculture and precision farming using drone technology.  Through a Memorandum of Understanding (MOU), IRRI and XAG will collaborate to validate the application of smart agriculture technologies in rice-based cropping systems through experimentation and research.

XAG, through its Philippine partner Agridom, has donated agricultural drones to the International Rice Research Institute (IRRI) to support its mission of advancing precision agriculture and sustainable farming practices. Agridom pioneered the introduction of XAG agricultural drones in the Philippines, bringing cutting-edge technology to local farmers and institutions. This collaboration with IRRI demonstrates Agridom’s unwavering commitment to driving agricultural innovation and empowering the sector with tools that enhance productivity and sustainability.

“Drones have been increasingly used for high throughput phenotyping, crop monitoring, improving agricultural productivity, and supporting precision farming. By providing efficient tools for crop monitoring, precision input application, and data-driven decision-making, drones provide the potential to significantly reduce costs and increase yields, optimizing resource use and minimizing environmental impact,” explained IRRI Senior Scientist and Digital Agriculture and Precision Farming Lead Engr. Steve Klassen.

This meant that drones could rapidly provide measurements of traits related to growth, yield, and stress adaptation. This technology is particularly valuable to smallholder farmers who must improve their productivity and reduce production costs to be competitive and stay in business in response to climate change, labor shortages, and higher input costs.

However, drone adoption in the Philippines is hindered by limited access to technology, lack of standard protocols, financial resources, and regulatory constraints. “To overcome these challenges, we need a comprehensive approach that involves targeted training, guidelines for best practices, financial incentives, and supportive government policies.”, Klassen said.

Klassen’s team is also working with the Philippine Department of Agriculture (DA) – National Program, Philippine Rice Research Institute (PhilRice), and their allied bureaus on the Drones4Rice Project, which aims to streamline and standardize drone protocols for applying seeds, fertilizers, and pesticides in the Philippines. The donated drones will support the ongoing Drones4Rice project and other IRRI global initiatives on sustainable farming and digital accelerators.

“IRRI is a key research and technology partner in the Philippines, and through this effort, we hope to contribute to the country’s agricultural competitiveness through drone-based technologies.” shared XAG Head of International Business Wei Tong. “XAG’s agricultural drones can be applied to various precision farming scenarios, specifically but not limited to direct seeding, pesticide spraying, fertilizer operation, and remote sensing. We hope to expand our engagements abroad to strengthen global food security and tackle climate change, as rice is the primary staple food that feeds over half of the world’s population.”, Tong shared.

Beyond this collaboration, XAG is also a member of the IRRI-led Direct Seeded Rice Consortium (DSRC), which promotes direct seeding methods in rice cultivation by developing technologies and training farmers to adopt sustainable farming practices.

Indonesia, Malaysia, Philippines, India and Singapore record massive smartphone user bases

KUALA LUMPUR, Malaysia, Jan. 20, 2025 /PRNewswire/ — Global cloud communication platform, Infobip has unveiled a new report titled ‘RCS: A New Era of Customer Engagement,’ which highlights research by IDC on the transformative potential of Rich Communication Services (RCS) in the Asia-Pacific region. The research reveals how a global smartphone user base of 5.1 billion presents new opportunities for brands to deliver personalized, interactive, and secure messaging experiences through RCS, particularly in countries such as Indonesia (146.3 million users), Malaysia (28.6 million users), Philippines (60.4 million users), India (653.1 million users), and Singapore (6.4 million users). With iOS now supporting RCS, brands can reach a broader audience with rich, engaging content directly on users’ mobile phones.

As businesses increasingly adopt digital communication channels, the need for secure messaging has become critical with the rise in phishing attacks in 2024. With India, Japan, and Australia ranking among the top 10 most targeted countries, RCS helps businesses protect their customers from falling victim to phishing. By integrating verified sender IDs and brand logos, which add a vital layer of legitimacy to messaging campaigns, this security feature of RCS ensures that customers can easily distinguish authentic messages from malicious ones.

Beyond security, RCS empowers brands to deliver contextually relevant communication throughout the customer journey, fostering long-term customer value and loyalty. By 2029, the report predicts that 60% of G2000 firms will shift from traditional KPIs like sales and profit to experience-oriented metrics, such as customer journey analytics and omnichannel engagement. The effectiveness of RCS is already evident. In India, fintech platform BankBazaar saw an 80% higher click-through rate with RCS compared to SMS, which further increased to 130% with the use of GIFs. This innovation has doubled customer response rates and established RCS as a core component of their marketing strategy. Similarly, Niva Bupa, a leading insurance provider in India, achieved a 75% ROI and improved customer retention with RCS.

Ivan Ostojic, Chief Business Officer, Infobip, said, “As RCS becomes widely available on both Android and iOS, it is transforming the way brands interact with their customers. Highly personalized interactions have proven to be effective, with response rates several times higher than traditional communication channels, underscoring the value of tailoring communication to individual needs. With RCS, businesses can engage directly with customers through the native messaging app, delivering a more personalized and seamless experience.” He added, “RCS is not just a messaging channel but a vital component of a brand’s omnichannel strategy. In today’s competitive digital landscape, it empowers brands to build trust, drive engagement, and foster lasting relationships while meeting evolving customer expectations.”

Gain deeper insights into RCS and its impact on the APAC region by downloading the report. Click here.

About Infobip

Infobip is a global cloud communications platform that enables businesses to build connected experiences across all stages of the customer journey. Accessed through a single platform, Infobip’s omnichannel engagement, identity, user authentication and contact centre solutions help businesses and partners overcome the complexity of consumer communications to grow business and increase loyalty. It offers natively built technology with the capacity to reach over seven billion mobile devices and ‘things’ in 6 continents connected to over 9,700+ connections of which 800+ are direct operator connections. Infobip was established in 2006 and is led by its co-founders, CEO Silvio Kutić, Roberto Kutić and Izabel Jelenić.

Recent award wins include:

• Infobip named number one among Established Leaders in RCS Business Messaging in Juniper Research’s RCS Business Messaging Competitor Leaderboard 2024 (Nov 2024)
• Infobip named a Leader in the Gartner® Magic Quadrant™ for Communications Platform as a Service (CPaaS) 2024 for the second year running (June 2024)
• Infobip named to Fast Company’s Annual List of the World’s Most Innovative Companies (March 2024)
• Infobip named a leader in the CPaaS Leaderboard, Juniper Research (March 2024)
• Infobip ranked as number one Communications Platform as a Service (CPaaS) provider, in the inaugural MetriRank CPaaS Report from Metrigy (Dec 2023)
• Infobip named a leader in the CCaaS Leaderboard, Juniper Research (Dec 2023)
• Omdia Ranks Infobip as Leader for the second year running in its CPaaS Universe Report (Nov 2023)
• Infobip named a Leader in the Gartner® Magic Quadrant™ for Communications Platform as a Service (CPaaS) 2023 (Sept 2023)
• Infobip named a leader in the Juniper Customer Data Platform Leaderboard Report (July 2023)
• Infobip named a Leader in the IDC MarketScape: Worldwide Communications Platform-as-a-Service (CPaaS) 2023 Vendor Assessment (doc #US50607923, May 2023)